Culmination Bio and Cofactor Genomics Leverage Largest Biobank in the U.S. for PREDAPT Precision Medicine Clinical Trial

SALT LAKE CITY & SAN FRANCISCO–(BUSINESS WIRE)– #RNA–Culmination Bio and Cofactor Genomics leverage the largest biobank in the U.S. for the PREDAPT precision medicine clinical trial of 11 cancers.

Culmination Bio and Cofactor Genomics Leverage Largest Biobank in the U.S. for PREDAPT Precision Medicine Clinical Trial

SALT LAKE CITY & SAN FRANCISCO–(BUSINESS WIRE)– #RNA–Culmination Bio and Cofactor Genomics leverage the largest biobank in the U.S. for the PREDAPT precision medicine clinical trial of 11 cancers.